ArticleCell reports2020

Glioblastoma Cell Resistance to EGFR and MET Inhibition Can Be Overcome via Blockade of FGFR-SPRY2 Bypass Signaling.

Evan K Day et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.